|Age:||18 years or older|
|Keywords:||lung diseases, interstitial lung disease, ILD, Progressive Fibrosing Interstitial Lung Disease, Fibrosing Interstitial Lung Disease, extension study|
|Type:||Drug study, Phase 3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.